Analyst Ratings For CVS Health (NYSE:CVS)
Today, Raymond James lowered its price target on CVS Health (NYSE:CVS) to $75.00 per share.
There are 17 Buy Ratings, 5 Hold Ratings, 1 Strong Buy Ratings, no Sell Ratings on the stock.
The current consensus rating on CVS Health (NYSE:CVS) is Buy with a consensus target price of $79.3684 per share, a potential 49.33% upside.
Some recent analyst ratings include
- 4/18/2019-CVS Health (NYSE:CVS) has coverage initiated with a Buy ➝ Buy rating
- 4/15/2019-CVS Health (NYSE:CVS) had its Outperform ➝ Market Perform rating reiterated by CIBC
- 4/15/2019-CVS Health (NYSE:CVS) gets downgraded to Market Perform by Oppenheimer
- 4/10/2019-CVS Health (NYSE:CVS) has coverage initiated with a Outperform rating and $58.00 price target
- On 3/11/2019 C David Brown II, Director, bought 10,000 with an average share price of $53.18 per share and the total transaction amounting to $531,800.00.
- On 3/8/2019 David W Dorman, Director, bought 9,600 with an average share price of $52.71 per share and the total transaction amounting to $506,016.00.
- On 3/1/2019 Edward J Ludwig, Director, bought 4,000 with an average share price of $58.27 per share and the total transaction amounting to $233,080.00.
- On 3/1/2019 James David Clark, SVP, sold 1,664 with an average share price of $58.14 per share and the total transaction amounting to $96,744.96.
- On 2/1/2019 Jonathan C Roberts, COO, sold 77,639 with an average share price of $64.54 per share and the total transaction amounting to $5,010,821.06.
- On 2/1/2019 Larry J Merlo, Insider, sold 166,368 with an average share price of $64.51 per share and the total transaction amounting to $10,732,399.68.
- On 1/8/2019 Larry J Merlo, Insider, sold 166,368 with an average share price of $69.04 per share and the total transaction amounting to $11,486,046.72.
About CVS Health (NYSE:CVS)
CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services. The company's Retail/LTC segment sells prescription drugs and general merchandise, such as over-the-counter drugs, beauty products, cosmetics, and personal care products, as well as provides health care services through its MinuteClinic walk-in medical clinics. Its Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, medical management, Medicare plans, PDPs, Medicaid health care management services, workers' compensation administrative services, and health information technology products and services. The company's customers include employers, insurance companies, unions, government employee groups, health plans, Medicare Part D prescription drug plans, Medicaid managed care plans, plans offered on public health insurance exchanges and private health insurance exchanges, other sponsors of health benefit plans, individuals, college students, workers, labor groups, and expatriates. As of December 31, 2018, it had approximately 40 leased on-site pharmacies, 25 leased retail specialty pharmacy stores, 20 specialty mail order pharmacies, and 90 branches for infusion and enteral services; and 9,900 retail locations and 1,100 MinuteClinic locations, as well as operated an online retail pharmacy Websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
Recent Trading Activity for CVS Health (NYSE:CVS)
Shares of CVS Health closed the previous trading session at 53,14 +0,60 1,15 % with 53.16 shares trading hands.